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Abstract
A brainstem syndrome is recognizable in patients presenting with a combination of visual
disturbances, incoordination, gait problems, speech and swallowing difficulties and new onset
sleep symptomatology. Brainstem disorders of subacute onset (onset and progression with
accumulation of disabling deficits in 6-12 weeks) are generally of autoimmune, infectious,
inflammatory or infiltrative neoplastic cause. An autoimmune or infectious brainstem disorder
may be referred to as brainstem encephalitis or rhombencephalitis. We describe a patient with a
paraneoplastic autoimmune rhombencephalitis, in whom diagnostic clues included: diverse
visual and sleep symptoms, trismus and choking in the history; see-saw nystagmus, opsoclonus,
dysarthria, jaw dystonia and episodic laryngospasm on examination; subtle but longitudinal and
non-enhancing T2 MRI abnormalities in the brainstem and upper cervical cord, and oligoclonal
bands in CSF. His movement disorder-specific neural IgG profile revealed ANNA-2 (anti-Ri)
and KLHL-11-IgG. Both are biomarkers of paraneoplastic brainstem encephalitis, and KLCHL11-IgG has been reported to accompany germ cell tumors, which was found in a solitary
metastasis to the left inguinal lymph node in our patient, along with an atrophic left testis.
Multidisciplinary treatment (autoimmune neurology, sleep medicine, ophthalmology, and
physiatry) led to significant clinical improvements. This case provides a framework for
evaluation of patients with subacute onset brainstem syndromes, and the investigation and
management of those with paraneoplastic and other autoimmune diseases.
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Section 1
A 43-year-old man, with prior left testicular torsion, presented with 2 weeks of imbalance, gait
incoordination, double and blurred vision, and vertigo, and right lower extremity weakness. He
denied confusion, disorientation, or associated memory issues. Observed eye movement
abnormalities and ataxia upon initial evaluation, and elevated white cell count and protein in
CSF, led to a Miller-Fisher syndrome diagnosis. He was treated with IVIg, accompanied by
improvement in vertigo. Eight weeks later, diplopia and oscillopsia occurred, and he had jaw
opening difficulties and clenching episodes (trismus), and hypersialorrhea. He required pureed
diet, and subsequently gastrostomy tube for nutrition. He developed severe daytime
hypersomnolence and sleep-related complex motor behaviors, with violent, thrashing limb
movements, and screaming and shouting vocalizations. He was briefly hospitalized after a
possible isolated seizure, though never confirmed (EEG did not reveal epileptiform discharges).
Sixteen weeks into his illness, he developed choking episodes, nocturnal stridor and hypoxia. He
was hospitalized again. He developed acute respiratory failure necessitating mechanical
ventilation.
On examination, he had horizontal plane ophthalmoplegia (not overcome with vestibular ocular
reflex), esotropia, jerk see-saw vertical nystagmus (Video 1) and superimposed opsoclonic bursts
(Video 2). He had mixed flaccid-hyperkinetic dysarthria, and jaw closing dystonia (Video 2). He
had oral-phase and pharyngeal dysphagia. He was wheelchair bound, only taking steps with a
walker and maximum assistance. He had moderate upper extremity dysmetria (minimal in the
lower extremities) and normal limb tone and strength. Jaw jerk and deep tendon reflexes were
brisk, and sensory examination was normal. Hoffman and Babinski signs were negative. A left
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inguinal mass was detected. Episodic shortness of breath accompanied by cyanosis
(laryngospasm) was noted. Tracheostomy placement precluded polysomnographic studies.
Questions for considerations:
1. What is the significance of symptom onset and progression?
2. Where do the symptoms and signs localize to?
3. What is the differential diagnosis?
4. What tests would you perform?

Section 2
The onset and progression, leading to significant disability within 6-12 weeks is consistent with a
subacute disorder.1 The age of onset and progression rate is atypical for hereditary disease and
degenerative CNS diseases (except for Creutzfeldt-Jakob disease, where ataxia could be
prominent and progress rapidly).
While the gait and balance difficulties, and extremity weakness do not localize well, the bilateral
horizontal gaze palsies with opsoclonus, jerk see-saw nystagmus, laryngospasm, jaw dystonia,
dysarthria, dysphagia and probable REM sleep behavior disorder assist in brainstem syndromic
localization. Jerk see-saw nystagmus localizes to either medulla or mesodiencephalon, whereas
pendular see-saw nystagmus localizes to the brainstem-mesodiencephalic junction.2 A possible
seizure suggested CNS multifocality, though this event could have represented hyperekplexia or
generalized dystonic posturing with brainstem localization. While subacute peripheral nervous
system disorders such as myasthenia gravis, Lambert-Eaton syndrome, and Miller-Fisher
syndrome were considered, they were excluded because of CNS signs present, and absence of
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fatigable weakness, autonomic and neuropathic signs. A brainstem disorder was the appropriate
localizing syndrome. Differential diagnostic considerations for subacute onset brainstem
disorders include toxic, infectious, neoplastic, inflammatory, and autoimmune causes (Table).
Opsoclonus (with or without myoclonus) is rarely encountered beyond immune-mediated
etiologies.3
A comprehensive evaluation including blood tests, MRI imaging, CSF analysis, and EEG was
undertaken. General tests (CBC with differential, electrolytes, fasting glucose, C-reactive
protein, liver function tests, urinalysis, chest x-ray) were all normal. Second-line blood tests were
also normal (vitamin B12, methylmalonic acid, folate, antinuclear antibody with connective
tissue diseases cascade, ANCA vasculitis panel and celiac disease serology). Discreet,
longitudinally-extensive T2 hyperintensities in the pontine and medullary tegmentum, extending
into the cervical cord (Figure), without mass effect, without enhancement has been reported in
paraneoplastic disorders.3 Typical features of demyelinating disease and CLIPPERs (pontine
perivascular enhancement) were absent.4 CSF studies revealed 37 white blood cells/mL (normal,
<5/mL, 92%), lymphocyte-predominant, protein of 59 (normal, £35 mg/dL), normal glucose,
normal IgG index and synthesis rate, and 4 CSF-exclusive oligoclonal bands (normal, <2). An
elevated white cell count could also be encountered in infectious meningoencephalitis, but CSFexclusive oligoclonal bands (or elevated CSF kappa free light chains) are indicative of CNS
inflammation.5 In addition, gram stain, aerobic and anaerobic cultures, and cytology were
negative. CSF tests for herpes viruses, Lyme disease and listeria were also negative. EEG
exhibited diffuse, generalized nonspecific slowing. Left groin ultrasound revealed atrophic testis
and enlarged lymph node. CT whole-body did not reveal malignancy.
Questions for considerations:
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1. What additional testing would you obtain to determine the diagnosis?
Section 3
The subacute onset, syndromic features and inflammatory CSF, made the term
rhombencephalitis appropriate. The presence of opsoclonus, the groin mass, the ‘tractopathy’
MRI findings, and CSF-exclusive oligoclonal bands made an autoimmune paraneoplastic cause
most likely. A profile of neural antibodies pertinent to paraneoplastic and other autoimmune
movement disorders was requested in serum (Table), revealing antineuronal nuclear antibody
type-2 (ANNA-2, or anti-Ri) and kelch-like protein 11 (KLCHL11)-IgG. An excisional biopsy of
the left inguinal lymph node revealed neoplastic components (Figure, A-D). Marked SALL4
reactivity was observed by immunohistochemistry, consistent with germ cell tumor. Marked
NOVA1 (Ri, but not KLCHL-11) immunoreactivity was noted in the nuclei. PET-CT showed no
evidence of retroperitoneal involvement. The patient underwent orchiectomy of the left testis
(without additional chemotherapy). Pathology revealed a fibrotic testis surrounded by atrophic
and sclerotic seminiferous tubules, without malignancy. Serial follow-up body imaging by FDG
PET-CT over 1 year (and planned for 2 more) did not reveal cancer recurrence. Immune
treatment (IV methylprednisolone 1g weekly for 12 weeks, and cyclophosphamide 1g/m2
monthly for 6 months) was followed by near resolution of nystagmus and opsoclonus. Mobility
gradually improved to the patient walking with a gait belt after 6 months follow-up, with further
rehabilitation planned. The esotropia was treated with a 25-prism diopter (base out) Fresnel
prism, but the patient continued to have significant horizontal gaze palsies. Jaw dystonia only
marginally improved with a combination of botulinum toxin therapy, clonazepam and tizanidine,
and ongoing gastrostomy feeding support was required. The patient received non-invasive
positive-pressure ventilation with bilevel positive airway pressure for sleep-disordered breathing.
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The patient’s probable REM sleep behavior disorder improved with nighttime clonazepam, and
daytime sleepiness improved with methylphenidate.
Discussion
Paraneoplastic rhombencephalitis should be considered in patients with subacute onset of gait,
coordination, visual, speech and swallowing difficulties.1 Broadly, brainstem encephalitis may be
ataxia-predominant (with accompanying vertigo and other visual symptoms) or may mimic
atypical neurodegenerative parkinsonism with prominence of supranuclear gaze palsy, postural
instability and falls. Though infectious causes (such as listeriosis), neoplasia and other
inflammatory disorders (such as sarcoidosis) can present subacutely, brain imaging would
generally demonstrate mass effect, basilar leptomeningeal or parenchymal enhancement. Other
major categories can largely be excluded by their onset, hyperacute (stroke or hemorrhage) or
insidious (such primary brain tumor or progressive supranuclear palsy).
In addition to subacute onset and progression, clues to autoimmunity include opsoclonus (jaw
closing dystonia and laryngospasm, reported with ANNA-2, IgLON5 and KLCHL-11
antibodies).6-8 A locked jaw is also sometimes encountered in progressive encephalomyelitis
with rigidity and myoclonus (usually glycine receptor antibody positive).9 Sleep disorders and
episodic laryngospasm are common in brainstem encephalitis and should be sought out and
treated. Incipient symptoms of sleep disordered breathing may be a harbinger of nocturnal
respiratory arrest, particularly in Ma2 and IgLON5 autoimmunity.10,11 Early hearing loss is
encountered in 40% of KLCHL-11 patients.8 Ataxia, vertigo, hearing loss, and tinnitus are more
common with KLHL11 encephalitis than with Ma2 encephalitis. DPPX encephalitis may present
with diarrhea and weight loss.12 Type 1 diabetes or thyroid disease, and stiff-person phenomena
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autoimmunity may preexist or coexist in GAD65 autoimmunity.13 Some patients with
paraneoplastic neurological disorders may have multifocal presentations and different
phenotypes can be encountered with most autoantibodies (such as IgLON5 autoimmunity which
may present with chorea, ataxia, or parkinsonian brainstem syndrome).7
A neural IgG profile assists in confirming an autoimmune diagnosis, but also assists in predicting
cancer type in patients with a paraneoplastic cause. Typical accompaniments for ANNA-2 are
breast adenocarcinoma or lung small cell carcinoma, and for KLCHL-11 seminoma (testicular or
extra-testicular) and germ cell testicular neoplasms (as in our patient). KLHL-11 is less abundant
than Ri protein, perhaps explaining the lack of tumor staining. Though the autoantibody
diagnosis was made in serum, neurological phenotype-specific autoantibody evaluations in both
serum and CSF are generally recommended.1 The patient was at risk for testicular neoplasia
given the atrophic testis.14
Neural IgG profiles also inform treatment decisions and prognosis derived from prior clinical
experience. For instance, DPPX-IgG potentially has pathogenic effects upon binding to the
extracellular domain of DPPX potassium channel subunit.15 Improvements in neurological
symptoms may occur upon receiving antibody-depleting plasma exchange and rituximab.1 On
the other hand, KLCHL-11 and Ri proteins are nuclear proteins, and not accessible to effects of
IgGs. Rather, these IgGs appear to be biomarkers of CD8+ cytotoxic T cell-mediated
pathophysiology and may be more amenable to cancer treatment and T cell suppression with
chemotherapy, corticosteroids and cyclophosphamide.1,6,8
In summary, subacute onset of eye movement abnormalities and postural instability should
prompt consideration of brainstem encephalitis, particularly when accompanied by one or more
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of dysarthria, dysphagia, sleep disorders, trismus and laryngospasm. Neural antibody testing
profiles can assist in autoimmune neurological and cancer diagnosis.
Table. Differential diagnosis of acquired brainstem syndromes
Category
Ischemic stroke
Hemorrhage
Primary brain neoplasm
Lymphoma
Carcinomatosis
Autoimmune rhombencephalitis (alternate name, and associated cancer
where applicable) *
ANNA-2 (anti-Ri; small cell carcinoma, breast adenocarcinoma)
DPPX (Occasional B cell neoplasias)
IgLON5
GAD65
GQ1B (Bickerstaff encephalitis)
KLCHL-11 (Testicular seminoma)
Ma2 (Testicular germinoma)
MOG
PCA-1 (anti-Yo; breast & gynecologic adenocarcinomas)
PCA-Tr (anti-DNER; lymphoma)
Other autoimmune or inflammatory rhombencephalitis categories
figMultiple sclerosis
Sarcoidosis
CLIPPERS
Behcet disease
Systemic lupus erythematous
Vasculitis (multiple cranial neuropathies)
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Infectious rhombencephalitis
Listeria
Herpes viruses (HSV, VZV, EBV, CMV)
Tuberculosis
Other brainstem disorders
Degenerative ‘Parkinsonism-plus’
supranuclear palsy)

syndromes

(e.g.

progressive

Metronidazole toxicity
*Brainstem syndromes considered characteristic. Brainstem disorders also described in the context of paraneoplastic
or other autoimmune encephalomyeloneuropathies accompanying the following IgG antibodies: ANNA-1 (anti-Hu),
PCA-2 (MAP1B-IgG), amphiphysin, ANNA-3, AGNA, CRMP-5, glycine receptor.
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Figure. Radiologic and tumor histopathologic findings.

MRI brain (T2 FLAIR) and cervical cord (T2) reveal T2 hyperintensity in pontine (A) and
medullary tegmentum (B), arrows, which extended to the upper cervical cord (C). (D.a) The left
inguinal lymph node biopsy from a 43-years-old male patient with testicular mass shows
metastatic neoplastic components (hematoxylin and eosin stain). The tumor cells present variable
morphologies. Most of the tumor cells show a large nucleus with prominent nucleoli (D.b,
enlarged view of D.a). (E.a) Immunohistochemistry shows marked SALL4 immunoreactivity in
the tumor cells which is consistent with germ cell tumor (enlarged view in E.b). (F.a) The tumor
cells show no KLHL11 immunoreactivity (enlarged view in F.b). (G.a) Tumor cells demonstrate
marked NOVA1 immunoreactivities in the nuclei (enlarged views in G.b and G.c). Scale bars:
100 µm (D.a, E.a, F.a, G.a), 50 µm (G.b), 20 µm (D.b, E.b, F.b, G.c).
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Video 1. Jerk see-saw nystagmus, observed when the patient was in ICU early on in his illness.

Cyclically, and with a jerky appearance, one eye rises and intorts, as the other falls and extorts,
followed by reversal of the same movements.
Video 2. Three sequential video segments demonstrating bursts of opsoclonus, dysarthria and

jaw closing dystonia and trismus.

WNL-2022-200908_vid1 --http://links.lww.com/WNL/C172
WNL-2022-200908_vid2 --http://links.lww.com/WNL/C173
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